Bleeding diathesis due to thromboxane synthesis deficiency

Bleeding diathesis due to thromboxane synthesis deficiency is an extremely rare inherited platelet function disorder characterized by impaired production of thromboxane A2 (TXA2), a potent mediator of platelet aggregation and vasoconstriction. Thromboxane A2 is synthesized from arachidonic acid through the action of the enzyme thromboxane synthase (also known as thromboxane A synthase 1, encoded by the TBXAS1 gene). When this enzyme is deficient or dysfunctional, platelets cannot generate adequate thromboxane A2, leading to defective platelet aggregation and a resulting bleeding tendency. The condition primarily affects the hematologic system, manifesting as a mild to moderate bleeding diathesis. Key clinical features include easy bruising, prolonged bleeding from cuts or surgical procedures, mucocutaneous bleeding such as epistaxis (nosebleeds), menorrhagia (heavy menstrual bleeding) in affected women, and excessive bleeding after dental extractions or trauma. Platelet counts are typically normal, but platelet aggregation studies reveal impaired responses to arachidonic acid and collagen, while responses to exogenous thromboxane analogs remain intact, helping to distinguish this condition from other platelet function disorders such as aspirin-like defects or cyclooxygenase deficiency. Treatment is primarily supportive and symptomatic. Patients are advised to avoid antiplatelet medications such as aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs), which could further impair platelet function. For minor bleeding episodes, local hemostatic measures may suffice. Desmopressin (DDAVP) may be used to enhance hemostasis in some patients. Platelet transfusions may be required for severe bleeding or in preparation for major surgical procedures. Antifibrinolytic agents such as tranexamic acid can also be helpful, particularly for mucosal bleeding. No curative therapy is currently available.

Common questions about Bleeding diathesis due to thromboxane synthesis deficiency